GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EVIO Inc (OTCPK:EVIO) » Definitions » 12-1 Month Momentum %

EVIO (EVIO) 12-1 Month Momentum % : 100.00% (As of Nov. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is EVIO 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-11-15), EVIO's 12-1 Month Momentum % is 100.00%.

The industry rank for EVIO's 12-1 Month Momentum % or its related term are showing as below:

EVIO's 12-1 Month Momentum % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.185 vs EVIO: 100.00

Competitive Comparison of EVIO's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, EVIO's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EVIO's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EVIO's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where EVIO's 12-1 Month Momentum % falls into.



EVIO  (OTCPK:EVIO) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EVIO  (OTCPK:EVIO) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


EVIO 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of EVIO's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


EVIO Business Description

Traded in Other Exchanges
N/A
Address
2654 Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is engaged in providing analytical testing and advisory services to the emerging legalized cannabis industry. The company performs analytical testing for cannabis and cannabis products including hemp and CBD products. The company tests products to verify to meet regulatory requirements for sale. The company also provides consulting services for the residential and commercial construction and remodeling industry.
Executives
William Waldrop director, 10 percent owner, officer: CEO 9484 S. EASTERN AVE #141 LAS VEGAS NV 89123
Lori Jean Glauser director, 10 percent owner, officer: COO 62930 O B RILEY RD. #300 BEND OR 97703
Anthony R. Smith director, 10 percent owner, officer: President/CSO 1467 SISKIYOU #126 ASHLAND OR 97520

EVIO Headlines

From GuruFocus

EVIO Inc. Hires Jeremy L Sackett as Chief Science Officer

By ACCESSWIRE ACCESSWIRE 05-13-2021

EVIO Inc. Closes Acquisition with MRX Labs, LLC

By PRNewswire PRNewswire 07-11-2018

EVIO Canada's Keystone Labs Receives Health Canada Approval

By PRNewswire PRNewswire 09-10-2018

EVIO Labs Massachusetts Announces ISO 17025 Accreditation

By PRNewswire PRNewswire 08-02-2018

EVIO Inc. Provides Shareholder Update

By PRNewswire PRNewswire 08-15-2018

EVIO Inc. Closes First Tranche Equity Financing

By Marketwired Marketwired 04-10-2019